Dela Cruz, John Fier J.
HRN: 12-89-78 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/19/2023
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
07/19/2023
07/26/2023
IV
235mg
Q8H
Intestinal Amoebiasis
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes